Literature DB >> 22450783

Biochemical characterization of recombinant L-asparaginase (AnsA) from Rhizobium etli, a member of an increasing rhizobial-type family of L-asparaginases.

Angelica Moreno-Enriquez1, Zahaed Evangelista-Martinez, Edith G Gonzalez-Mondragon, Arturo Calderon-Flores, Roberto Arreguin, Ernesto Perez-Rueda, Alejandro Huerta-Saquero.   

Abstract

We report the expression, purification, and characterization of L-asparaginase (AnsA) from Rhizobium etli. The enzyme was purified to homogeneity in a single-step procedure involving affinity chromatography, and the kinetic parameters K(m), V(max), and k(cat) for L-asparagine were determined. The enzymatic activity in the presence of a number of substrates and metal ions was investigated. The molecular mass of the enzyme was 47 kDa by SDS-PAGE. The enzyme showed a maximal activity at 50 degrees C, but the optimal temperature of activity was 37 degrees C. It also showed maximal and optimal activities at pH 9.0. The values of K(m), V(max), k(cat), and k(cat)/K(m) were 8.9 +/- 0.967 × 10⁻³ M, 128 +/- 2.8 U/mg protein, 106 +/- 2 s⁻¹, and 1.2 +/- 0.105 × 10⁴ M⁻¹s⁻¹, respectively. The L-asparaginase activity was reduced in the presence of Mn²⁺, Zn²⁺, Ca²⁺, and Mg²⁺ metal ions for about 52% to 31%. In addition, we found that NH₄⁺, L-Asp, D-Asn, and beta-aspartyl-hydroxamate in the reaction buffer reduced the activity of the enzyme, whereas L-Gln did not modify its enzymatic activity. This is the first report on the expression and characterization of the L-asparaginase (AnsA) from R. etli. Phylogenetic analysis of asparaginases reveals an increasing group of known sequences of the Rhizobialtype asparaginase II family.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450783     DOI: 10.4014/jmb.1107.07047

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  8 in total

1.  Reduction of acrylamide level through blanching with treatment by an extremely thermostable L-asparaginase during French fries processing.

Authors:  Shaohua Zuo; Tao Zhang; Bo Jiang; Wanmeng Mu
Journal:  Extremophiles       Date:  2015-06-16       Impact factor: 2.395

2.  Biochemical characterization of a novel L-Asparaginase with low glutaminase activity from Rhizomucor miehei and its application in food safety and leukemia treatment.

Authors:  Linhua Huang; Yu Liu; Yan Sun; Qiaojuan Yan; Zhengqiang Jiang
Journal:  Appl Environ Microbiol       Date:  2013-12-20       Impact factor: 4.792

Review 3.  Enzymes in Metabolic Anticancer Therapy.

Authors:  Maristella Maggi; Claudia Scotti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Asparaginase-Phage P22 Nanoreactors: Toward a Biobetter Development for Acute Lymphoblastic Leukemia Treatment.

Authors:  Cristina Díaz-Barriga; Francisca Villanueva-Flores; Katrin Quester; Andrés Zárate-Romero; Ruben Dario Cadena-Nava; Alejandro Huerta-Saquero
Journal:  Pharmaceutics       Date:  2021-04-22       Impact factor: 6.321

5.  Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.

Authors:  Alejandro Huerta-Saquero; Zahaed Evangelista-Martínez; Angélica Moreno-Enriquez; Ernesto Perez-Rueda
Journal:  Bioengineered       Date:  2012-08-16       Impact factor: 3.269

6.  Crystal structures of the elusive Rhizobium etli L-asparaginase reveal a peculiar active site.

Authors:  Joanna I Loch; Barbara Imiolczyk; Joanna Sliwiak; Anna Wantuch; Magdalena Bejger; Miroslaw Gilski; Mariusz Jaskolski
Journal:  Nat Commun       Date:  2021-11-18       Impact factor: 14.919

7.  Massive annotation of bacterial L-asparaginases reveals their puzzling distribution and frequent gene transfer events.

Authors:  Andrzej Zielezinski; Joanna I Loch; Wojciech M Karlowski; Mariusz Jaskolski
Journal:  Sci Rep       Date:  2022-09-22       Impact factor: 4.996

Review 8.  Molecular Analysis of L-Asparaginases for Clarification of the Mechanism of Action and Optimization of Pharmacological Functions.

Authors:  Marina V Pokrovskaya; Vadim S Pokrovsky; Svetlana S Aleksandrova; Nikolay N Sokolov; Dmitry D Zhdanov
Journal:  Pharmaceutics       Date:  2022-03-09       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.